Article
We Are Underprepared for Bedaquiline Resistance: A Call for Clinical and Programmatic Readiness.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 8 Jul 2026
Cross Gail Brenda, Walker Harry N, Hasan Tasnim, Berry Catherine
Abstract excerpt
Bedaquiline has transformed the treatment of multidrug-resistant tuberculosis (MDR-TB). However, bedaquiline resistance now threatens these gains. Emerging surveillance data demonstrate both baseline and acquired resistance across high-burden settings, with bedaquiline-resistant disease associated with poor clinical outcomes, high mortality, and growing evidence of transmission. In this Perspective, we examine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
